Clinical trial NCT06616285: The Effects of a Hungarian Multidomain Lifestyle Intervention on Brain Health in Older Adults
Official title: The Effects of a Hungarian Multidomain Lifestyle Intervention on Brain Health in Older Adults
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Neurocognitive Aging
Healthy Aging
Keywords: Brain
Healthy Aging
Multidomain intervention
Neurocognitive Aging
Lead sponsor: Research Centre for Natural Sciences
Sponsor class: OTHER
Collaborators: name: HUN-REN Institute of Experimental Medicine
name: Semmelweis University
First posted: 2024-09-27
Enrollment: 80
Sex: ALL
Minimum age (years): 65
Maximum age (years): 75
Standard ages: OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomised controlled trial. Participants will be randomised either into the Folk Dance Multidomain Lifestyle Intervention Group or the Self-Guided Multidomain Lifestyle Intervention Group. The intervention will be delivered over a period of 6 months.
Primary purpose: PREVENTION

Brief summary: Maintaining brain health in older adults is a critical social and economic challenge given the rising prevalence of neurodegenerative disorders. Despite extensive research, effective pharmacological treatments for dementia remain limited, emphasising the need for early diagnosis and prevention of cognitive decline. Research suggests that lifestyle and modifiable factors account for approximately 40% of dementia risk, highlighting the potential of personalised lifestyle interventions to delay or prevent the onset of dementia. The original FINGER study demonstrated that a multi-domain lifestyle intervention simultaneously targeting dietary habits, physical and cognitive activity, as well as social interactions can effectively prevent cognitive decline and dementia.

The HUN-MLI-BRAIN trial investigates the impact of a Hungarian lifestyle intervention on brain health in older adults and is based on the FINGER multi-domain intervention. This randomised controlled study aims to maintain and enhance neurocognitive function and prevent cognitive decline in older adults through a multi-domain lifestyle program, which simultaneously targets dietary habits, physical and cognitive activity, and social engagement.

The primary goal of the HUN-MLI-BRAIN trial is to evaluate the impact of the intervention programme on neurocognitive functions and adaptive changes in large-scale brain networks at the individual level using the precision structural and functional MRI methods as well as resting-state EEG frequency-domain analyses. In addition, the influence of the intervention will be assessed in a wide range of cognitive and personal domains. The potential relationship between brain structure and function, cognitive performance, lifestyle factors, and dementia risk factors will be evaluated.

80 people without substantial cognitive impairment or dementia will be recruited into the programme in Budapest, Hungary. Participants will be randomly allocated 1:1 either to the multi-domain, folk dancing lifestyle intervention group or the self-guided, multi-domain lifestyle intervention group. The self-guided intervention encompasses multi-domain lifestyle recommendations on diet, physical and mental training, and health checks via the Polar Pacer smart watch. The folk dancing intervention includes structured, one-hour folk dancing sessions three times per week, which were specifically developed to foster physical and cognitive function whilst facilitating social interaction. Participants in this group will also receive intensive and tailored lifestyle recommendations aimed at improving physical and mental functioning. The duration of the intervention programme is 6 months. Participants will complete assessment visits before and after the intervention.

The HUN-MLI-BRAIN trial holds significant potential for advancing our understanding of how lifestyle interventions may impact brain function. The use of advanced, precision neuroimaging techniques will offer novel insights into the adaptive changes in brain networks and potentially lead to more effective, personalised interventions for maintaining brain health in older adults.

Detailed description: Participants will first complete a short phone call designed to screen for eligibility and exclusion criteria. Selected participants will be invited for an in-house assessment, during which they will be further screened for cognitive, physical, and lifestyle risk factors as well as MRI scanning compatibility. Using the Mini-Mental State Examination, a board-certified neurologist will also screen participants for cognitive impairment.

Participants will be invited for several baseline and post-intervention assessments on separate days. First, eligible participants will complete a complex cognitive assessment. Next, EEG and pupillometry data will be collected from participants during rest and the completion of a probabilistic reversal learning task, which evaluates reinforcement learning behaviour and related neural mechanisms. Crucially, participants will also complete structural and functional MRI assessments. Using precision resting-state functional MRI, the study will examine large-scale brain network segregation as well as network-specific within and cross-network connectivity changes, which are known to be affected by ageing and neuropsychiatric diseases. A novel multi-echo multiband sequence, with enhanced BOLD signal sensitivity and reduced image artefacts, will be employed to improve test-retest reliability. During data collection, special care will be taken to ensure the availability of a sufficient amount of clean resting-state fMRI data, which is essential to ensure the accuracy and validity of the findings. Finally, blood samples will be collected from each participant.

Following all baseline assessments, participants will be randomised into the folk dancing or self-guided lifestyle intervention groups. Block-randomisation will be computerised with a targeted assignment ratio of 1:1 and stratification for age and sex.

Eligibility criteria: Inclusion Criteria:

* Age of 65-75 years
* Proficiency in the local (Hungarian) language
* Ability to perform all the three components of the Short Physical Performance Battery (score of at least 1 in each component)

Exclusion Criteria:

* Previous diagnosis of mild cognitive impairment or dementia, including current use of medications for memory impairment
* Suspected mild cognitive impairment or dementia after screening assessments, based on clinical judgement
* Contraindication for MRI scanning (e.g., metal implants, claustrophobia, excessive movement, etc.)
* History of any significant neurological condition, including Parkinson's disease, Huntington's disease, normal pressure hydrocephalus, brain tumours, progressive supranuclear palsy, seizure disorder, subdural heamatoma, multiple sclerosis, or history of stroke, transient ischemic attack, or any significant head trauma with persistent neurologic sequelae or known structural brain abnormalities
* History of major depression, bipolar disorder, schizophrenia
* Chronic medication use that could reasonably affect cognition, movement, or brain imaging measures
* Active substance-related and addictive disorders
* Current use of narcotics and psychoactive medications
* Cognitive impairment based on the Mini-Mental State Examination (MMSE, raw score less than 26)
* Reduced capacity for decision-making, unable to provide consent or complete study assessments, based on clinical judgement
* Conditions that prevent safe study participation
* Current significant medical problems (e.g., malignant disease, cardiovascular disease, conduction disorder)
* History within the last 2 years of treatment for primary or recurrent malignant disease
* Poorly controlled or uncontrolled diabetes mellitus, cardiovascular, conduction, or pulmonary disease
* Conditions that prevent cooperation: severe visual, auditory, or communication impairment (i.e., colour blindness, uncorrected hearing loss)
* PI/Study Clinician discretion regarding medical status, suitability of participation, or concerns about adherence to intervention
* Ongoing participation in another clinical intervention study

Primary outcomes:
measure: Changes in Brain Functional Connectivity Measured with Resting-State fMRI
timeFrame: Baseline, 6 month
measure: Changes in Brain Function Measured with Resting-State EEG
timeFrame: Baseline, 6 month
Secondary outcomes:
measure: Connectivity Changes in Brain Reward System
timeFrame: Baseline, 6 month
measure: Connectivity Changes in the Brain's Default Mode Network
timeFrame: Baseline, 6 month
measure: Changes in Hippocampal Volume
timeFrame: Baseline, 6 month
measure: Changes in the Striatal Volume
timeFrame: Baseline, 6 month
measure: Changes in the Volume of Neuromodulatory Nuclei
timeFrame: Baseline, 6 month
measure: Changes in Brain Age
timeFrame: Baseline, 6 month
measure: Changes Resting-State EEG Frequency Band Ratio Measures
timeFrame: Baseline, 6 month
measure: Changes in Feedback-Related EEG and Pupil Responses
timeFrame: Baseline, 6 month
measure: Changes in Subjective Cost of Cognitive Effort
timeFrame: Baseline, 6 month
measure: Changes in Global Cognitive Function
timeFrame: Baseline, 6 month
measure: Changes in Episodic Memory
timeFrame: Baseline, 6 month
measure: Changes in Executive Function
timeFrame: Baseline, 6 month
measure: Changes in Processing Speed
timeFrame: Baseline, 6 month
measure: Changes in Blood Biomarkers
timeFrame: Baseline, 6 month
measure: Changes in Anthropometry
timeFrame: Baseline, 6 month
measure: Changes in Body Mass Index (BMI)
timeFrame: Baseline, 6 month
measure: Changes in Systolic Blood Pressure
timeFrame: Baseline, 6 month
measure: Changes in Diastolic Blood Pressure
timeFrame: Baseline, 6 month
measure: Changes in Hand Grip Strength
timeFrame: Baseline, 6 month
measure: Changes in Physical Performance
timeFrame: Baseline, 6 month
measure: Changes in Physical Activity - Self-reported
timeFrame: Baseline, 6 month
measure: Changes in Physical Activity
timeFrame: 7-day wear period every 2 months
measure: Changes in Sleep
timeFrame: 7-day wear period every 2 months
measure: Changes in Subjective Sleep Quality
timeFrame: Baseline, 6 month
measure: Changes in Sleep Disorder
timeFrame: Baseline, 6 month
measure: Changes in Depressive Symptoms
timeFrame: Baseline, 6 month
measure: Changes in Well-Being
timeFrame: Baseline, 6 month
measure: Changes in Social Support
timeFrame: Baseline, 6 month
measure: Changes in Lifestyle
timeFrame: Baseline, 6 month
measure: Changes in Sarcopenia Symptoms
timeFrame: Baseline, 6 month
measure: Dementia Risk Score (CAIDE)
timeFrame: Baseline, 6 month
Other outcomes:
measure: Demographics and medical history
timeFrame: Baseline
measure: Instrumental Activities of Daily Living (IADL)
timeFrame: Baseline
measure: Dementia screening
timeFrame: Baseline
Locations:
city: Budapest
country: Hungary
facility: Brain Imaging Centre, HUN-REN Centre for Natural Sciences
Study officials:
affiliation: HUN-REN Centre for Natural Sciences
name: Zoltán Vidnyánszky, Ph.D., DSc.
role: PRINCIPAL_INVESTIGATOR
References:
citation: Barbera M, Lehtisalo J, Perera D, Aspo M, Cross M, De Jager Loots CA, Falaschetti E, Friel N, Luchsinger JA, Gavelin HM, Peltonen M, Price G, Neely AS, Thunborg C, Tuomilehto J, Mangialasche F, Middleton L, Ngandu T, Solomon A, Kivipelto M; MET-FINGER study team. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol. Alzheimers Res Ther. 2024 Jan 31;16(1):23. doi: 10.1186/s13195-023-01355-x.
citation: Barbera M, Perera D, Matton A, Mangialasche F, Rosenberg A, Middleton L, Ngandu T, Solomon A, Kivipelto M. Multimodal Precision Prevention - A New Direction in Alzheimer's Disease. J Prev Alzheimers Dis. 2023;10(4):718-728. doi: 10.14283/jpad.2023.114.